Palvella Therapeutics Inc (PVLA)
26.13 x 1 34.30 x 1
Post-market by (Cboe BZX)
28.14 +0.71 (+2.59%) 03/21/25 [NASDAQ]
26.13 x 1 34.30 x 1
Post-market 28.14 unch (unch) 16:01 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,369 | -8,482 | -4,892 | -24,543 | -19,959 |
| Depreciation Amortization | -30 | -30 | -30 | 1,904 | 2,102 |
| Accounts receivable | N/A | N/A | N/A | 5,307 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -789 | N/A |
| Other Working Capital | 953 | -1,771 | -3,963 | -48,141 | -33,933 |
| Other Operating Activity | 2,116 | 1,807 | 1,889 | 12,443 | 17,640 |
| Operating Cash Flow | $-8,330 | $-8,476 | $-6,996 | $-53,819 | $-34,150 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 2,318 | 2,176 | N/A | -171 | -184 |
| Purchase Of Investment | N/A | N/A | N/A | -22,835 | -15,270 |
| Sale Of Investment | 9,000 | 9,000 | 9,000 | 35,008 | 24,007 |
| Investing Cash Flow | $11,318 | $11,176 | $9,000 | $12,002 | $8,553 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 19,795 | 19,781 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $19,795 | $19,781 |
| Exchange Rate Effect | -1,021 | -365 | -316 | 783 | 75 |
| Beginning Cash Position | 17,396 | 17,396 | 17,396 | 38,635 | 38,635 |
| End Cash Position | 19,363 | 19,731 | 19,084 | 17,396 | 32,894 |
| Net Cash Flow | $1,967 | $2,335 | $1,688 | $-21,239 | $-5,741 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,330 | -8,476 | -6,996 | -53,819 | -34,150 |
| Capital Expenditure | N/A | N/A | N/A | -171 | -184 |
| Free Cash Flow | -8,330 | -8,476 | -6,996 | -53,990 | -34,334 |